Literature DB >> 22980806

Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A.

Yu-Chi Hou1, Shiuan-Pey Lin, Pei-Dawn Lee Chao.   

Abstract

Liquorice (root of Glycyrrhiza uralensis FISCH) is an ingredient of candies and used as a popular medicine in Europe and oriental countries. Cyclosporine (CsA), an immunosuppressant with narrow therapeutic window, is widely used in transplant patients. The absorption and disposition of CsA were associated with P-glycoprotein (P-gp) and cytochrome P450 3A4 (CYP3A4). This study investigated the effects of liquorice extract (LE) and its major ingredient, glycyrrhizin (GZ), on CsA pharmacokinetics in rats. The results indicated that LE and GZ significantly decreased the peak blood concentration and the areas under the curves of CsA in rats. Mechanism studies revealed that glycyrrhetic acid (GA), the major metabolite of GZ, significantly activated the functions of P-gp and CYP3A4. In conclusion, liquorice significantly reduced the oral bioavailability of CsA through activating P-gp and CYP3A4.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980806     DOI: 10.1016/j.foodchem.2012.07.061

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  21 in total

1.  Effects of Glycyrrhizic Acid on the Pharmacokinetics of Pristimerin in Rats and its Potential Mechanism.

Authors:  Xiufen Zhao; Yan Wu; Dongmei Wang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

Review 2.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

3.  The effects of 18β-glycyrrhetinic acid and glycyrrhizin on intestinal absorption of paeoniflorin using the everted rat gut sac model.

Authors:  Rui He; Yongsong Xu; Jingjing Peng; Tingting Ma; Jing Li; Muxin Gong
Journal:  J Nat Med       Date:  2016-10-17       Impact factor: 2.343

4.  Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling.

Authors:  Xue Qiao; Shuai Ji; Si-Wang Yu; Xiong-Hao Lin; Hong-Wei Jin; Yao-Kai Duan; Liang-Ren Zhang; De-An Guo; Min Ye
Journal:  AAPS J       Date:  2013-11-20       Impact factor: 4.009

Review 5.  Cyclosporine and herbal supplement interactions.

Authors:  D Colombo; L Lunardon; G Bellia
Journal:  J Toxicol       Date:  2014-01-12

6.  Revealing the Effects of the Herbal Pair of Euphorbia kansui and Glycyrrhiza on Hepatocellular Carcinoma Ascites with Integrating Network Target Analysis and Experimental Validation.

Authors:  Yanqiong Zhang; Ya Lin; Haiyu Zhao; Qiuyan Guo; Chen Yan; Na Lin
Journal:  Int J Biol Sci       Date:  2016-03-25       Impact factor: 6.580

7.  Induction of P-glycoprotein expression and activity by Aconitum alkaloids: Implication for clinical drug-drug interactions.

Authors:  Jinjun Wu; Na Lin; Fangyuan Li; Guiyu Zhang; Shugui He; Yuanfeng Zhu; Rilan Ou; Na Li; Shuqiang Liu; Lizhi Feng; Liang Liu; Zhongqiu Liu; Linlin Lu
Journal:  Sci Rep       Date:  2016-05-03       Impact factor: 4.379

8.  Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.

Authors:  Onat Kadioglu; Jingming Cao; Nadezda Kosyakova; Kristin Mrasek; Thomas Liehr; Thomas Efferth
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

9.  Physicochemical and Consumer Acceptance of Tofu Supplemented with Licorice Powder.

Authors:  Jun Ho Lee; Han San Jung
Journal:  Prev Nutr Food Sci       Date:  2017-12-31

10.  Alleviating the Intestinal Absorption of Rhein in Rhubarb through Herb Compatibility in Tiaowei Chengqi Tang in Caco-2 Cells.

Authors:  Ying Peng; Min Fan; Chongsheng Peng; Mengyue Wang; Xiaobo Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.